AMED - Amedisys, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
204.64
+5.42 (+2.72%)
At close: 4:00PM EDT

204.93 +0.29 (0.14%)
After hours: 5:08PM EDT

Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close199.22
Open201.05
Bid204.50 x 800
Ask223.49 x 1200
Day's Range199.72 - 204.70
52 Week Range121.00 - 218.44
Volume228,979
Avg. Volume405,849
Market Cap6.626B
Beta (5Y Monthly)0.94
PE Ratio (TTM)53.15
EPS (TTM)3.85
Earnings DateJul 29, 2020 - Aug 03, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est214.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
5% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Why the Earnings Surprise Streak Could Continue for Amedisys (AMED)
    Zacks

    Why the Earnings Surprise Streak Could Continue for Amedisys (AMED)

    Amedisys (AMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Lululemon, Fortinet Lead 5 Top Stocks In Or Near Buy Zones
    Investor's Business Daily

    Lululemon, Fortinet Lead 5 Top Stocks In Or Near Buy Zones

    Lululemon, Fortinet, Inphi, Costco Wholesale and Amedisys are leading stocks to watch, all in or near buy zones.

  • Why Biotechs Are Moving Up Among 4 Top-Rated Health Care Stocks
    Investor's Business Daily

    Why Biotechs Are Moving Up Among 4 Top-Rated Health Care Stocks

    The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

  • Amedisys Rides on Hospice Arm Expansion Amid Coronavirus Woes
    Zacks

    Amedisys Rides on Hospice Arm Expansion Amid Coronavirus Woes

    Amedisys (AMED) benefits from the recent acquisitions of hospice care providers, Asana Hospice, RoseRock Healthcare and Compassionate Care Hospice.

  • Should You Avoid Amedisys Inc (AMED)?
    Insider Monkey

    Should You Avoid Amedisys Inc (AMED)?

    In this article you are going to find out whether hedge funds think Amedisys Inc (NASDAQ:AMED) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]

  • DGX vs. AMED: Which Stock Is the Better Value Option?
    Zacks

    DGX vs. AMED: Which Stock Is the Better Value Option?

    DGX vs. AMED: Which Stock Is the Better Value Option?

  • Benzinga

    Benzinga's Top Upgrades, Downgrades For June 18, 2020

    Upgrades * Goldman Sachs changed the rating for CNO Financial Group Inc (NYSE: CNO) from Neutral to Buy. In the first quarter, CNO Finl Gr showed an EPS of $0.58, compared to $0.41 from the year-ago quarter. The stock has a 52-week-high of $20.93 and a 52-week-low of $8.79. CNO Finl Gr's stock last closed at $14.93 per share. * Credit Suisse changed the rating for Church & Dwight Co Inc (NYSE: CHD) from Neutral to Outperform. For the first quarter, Church & Dwight Co had an EPS of $0.83, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of $80.99 and a 52-week-low of $47.98. Church & Dwight Co's stock last closed at $75.35 per share. * DA Davidson upgraded the stock for MKS Instruments Inc (NASDAQ: MKSI) from Neutral to Buy. For the first quarter, MKS Instruments had an EPS of $1.54, compared to year-ago quarter EPS of $1.12. The stock has a 52-week-high of $122.30 and a 52-week-low of $66.87. MKS Instruments's stock last closed at $109.75 per share. * For Amedisys Inc (NASDAQ: AMED), Benchmark upgraded the stock from Hold to Buy. For the first quarter, Amedisys had an EPS of $1.05, compared to year-ago quarter EPS of $1.11. The stock has a 52-week-high of $218.44 and a 52-week-low of $115.41. Amedisys's stock last closed at $179.88 per share. * For Cloudflare Inc (NYSE: NET), Morgan Stanley upgraded the stock from Underweight to Equal-Weight. Interestingly, in the first quarter, Cloudflare's EPS was ($0.04). The stock has a 52-week-high of $36.00 and a 52-week-low of $14.50. Cloudflare's stock last closed at $35.81 per share. * RBC Capital upgraded the stock for Paylocity Holding Corp (NASDAQ: PCTY) from Sector Perform to Outperform. For the third quarter, Paylocity Holding had an EPS of $0.83, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $150.73 and a 52-week-low of $66.98. Paylocity Holding's stock last closed at $134.38 per share. * Barclays upgraded the stock for Pinnacle West Capital Corp (NYSE: PNW) from Equal-Weight to Overweight. In the first quarter, Pinnacle West Capital showed an EPS of $0.27, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $105.51 and a 52-week-low of $60.05. Pinnacle West Capital's stock last closed at $76.24 per share. * For Zscaler Inc (NASDAQ: ZS), Morgan Stanley upgraded the stock from Underweight to Equal-Weight. Zscaler earned $0.07 in the third quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $112.73 and a 52-week-low of $35.00. Zscaler's stock last closed at $106.18 per share. Downgrades * For Brighthouse Financial Inc (NASDAQ: BHF), Goldman Sachs downgraded the stock from Buy to Neutral. Brighthouse Financial earned $2.60 in the first quarter, compared to $2.21 in the year-ago quarter. The stock has a 52-week-high of $48.25 and a 52-week-low of $12.05. Brighthouse Financial's stock last closed at $31.90 per share. * Goldman Sachs downgraded the stock for Principal Financial Group Inc (NASDAQ: PFG) from Neutral to Sell. Interestingly, in the first quarter, Principal Financial Group's EPS was $1.15. The stock has a 52-week-high of $60.81 and a 52-week-low of $23.31. Principal Financial Group's stock last closed at $42.85 per share. * Citigroup changed the rating for Bank OZK (NASDAQ: OZK) from Buy to Neutral. In the first quarter, Bank OZK showed an EPS of $0.09, compared to $0.86 from the year-ago quarter. The stock has a 52-week-high of $31.76 and a 52-week-low of $14.20. Bank OZK's stock last closed at $24.30 per share. * Wells Fargo changed the rating for Accenture PLC (NYSE: ACN) from Overweight to Equal-Weight. Accenture earned $1.91 in the second quarter, compared to $1.73 in the year-ago quarter. The stock has a 52-week-high of $216.39 and a 52-week-low of $137.15. Accenture's stock last closed at $205.14 per share. * DZ Bank changed the rating for American Express Co (NYSE: AXP) from Buy to Hold. In the first quarter, American Express showed an EPS of $1.98, compared to $2.01 from the year-ago quarter. The stock has a 52-week-high of $138.13 and a 52-week-low of $67.00. American Express's stock last closed at $103.96 per share. * Berenberg changed the rating for Carnival Corp (NYSE: CCL) from Hold to Sell. For the second quarter, Carnival had an EPS of ($3.30), compared to year-ago quarter EPS of $0.66. The stock has a 52-week-high of $53.34 and a 52-week-low of $7.80. Carnival's stock last closed at $19.08 per share. * For DHT Holdings Inc (NYSE: DHT), Stifel downgraded the stock from Buy to Hold. In the first quarter, DHT Holdings showed an EPS of $0.44, compared to $0.12 from the year-ago quarter. The stock has a 52-week-high of $8.83 and a 52-week-low of $4.77. DHT Holdings's stock last closed at $5.54 per share. Initiations * Northland Capital Markets initiated coverage on Alphatec Holdings Inc (NASDAQ: ATEC) with an Outperform rating. The price target for Alphatec Holdings is set at $9.00. In the first quarter, Alphatec Holdings showed an EPS of ($0.33), compared to ($0.29) from the year-ago quarter. The stock has a 52-week-high of $7.93 and a 52-week-low of $2.19. Alphatec Holdings's stock last closed at $4.88 per share. * With a rating of Buy, SunTrust Robinson Humphrey initiated coverage on Editas Medicine Inc (NASDAQ: EDIT). The price target is set at $45.00 for Editas Medicine. For the first quarter, Editas Medicine had an EPS of ($0.69), compared to year-ago quarter EPS of ($0.60). The stock has a 52-week-high of $34.37 and a 52-week-low of $14.01. Editas Medicine's stock last closed at $29.89 per share. * Janney Capital initiated coverage on Invitation Homes Inc (NYSE: INVH) with a Buy rating. The price target for Invitation Homes is set at $34.00. For the first quarter, Invitation Homes had an EPS of $0.34, compared to year-ago quarter EPS of $0.33. The stock has a 52-week-high of $32.70 and a 52-week-low of $15.64. Invitation Homes's stock last closed at $28.41 per share. * Baird initiated coverage on CoStar Group Inc (NASDAQ: CSGP) with an Outperform rating. The price target for CoStar Gr is set at $755.00. CoStar Gr earned $2.44 in the first quarter, compared to $2.53 in the year-ago quarter. The stock has a 52-week-high of $746.70 and a 52-week-low of $500.24. CoStar Gr's stock last closed at $689.44 per share. * Stifel initiated coverage on Health Catalyst Inc (NASDAQ: HCAT) with a Buy rating. The price target for Health Catalyst is set at $36.00. In the first quarter, Health Catalyst earned ($0.16). The stock has a 52-week-high of $49.85 and a 52-week-low of $17.48. Health Catalyst's stock last closed at $29.69 per share. * RBC Capital initiated coverage on Tyler Technologies Inc (NYSE: TYL) with an Outperform rating. The price target for Tyler Technologies is set at $375.00. For the first quarter, Tyler Technologies had an EPS of $1.25, compared to year-ago quarter EPS of $1.22. The stock has a 52-week-high of $382.92 and a 52-week-low of $210.80. Tyler Technologies's stock last closed at $339.17 per share. * With a rating of Buy, Mizuho initiated coverage on Neoleukin Therapeutics Inc (NASDAQ: NLTX). The price target is set at $21.00 for Neoleukin Therapeutics. Neoleukin Therapeutics earned ($0.18) in the first quarter, compared to ($0.09) in the year-ago quarter. The stock has a 52-week-high of $15.35 and a 52-week-low of $2.53. Neoleukin Therapeutics's stock last closed at $13.52 per share. * MKM Partners initiated coverage on QEP Resources Inc (NYSE: QEP) with a Buy rating. The price target for QEP Resources is set at $3.00. In the first quarter, QEP Resources showed an EPS of $0.21, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $7.42 and a 52-week-low of $0.26. QEP Resources's stock last closed at $1.60 per share.See more from Benzinga * 14 Energy Stocks Moving In Thursday's Pre-Market Session * Kroger: Q1 Earnings Insights * 16 Financial Services Stocks Moving In Thursday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • GlobeNewswire

    Amedisys to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

    BATON ROUGE, La., June 17, 2020 -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B..

  • Amedisys (AMED) Up 2.5% Since Last Earnings Report: Can It Continue?
    Zacks

    Amedisys (AMED) Up 2.5% Since Last Earnings Report: Can It Continue?

    Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire

    Amedisys to Present at the 40th Annual William Blair Growth Stock Conference

    BATON ROUGE, La., June 05, 2020 -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B..

  • Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout
    Zacks

    Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout

    Amedisys (AMED) expects AseraCare business to add greater scale to its existing nationwide network.

  • GlobeNewswire

    Amedisys Completes Acquisition of AseraCare Hospice

    Amedisys, Inc. (AMED), a leading provider of home health, hospice and personal care, announced today that, through one of its wholly owned subsidiaries, it has closed on its acquisition of Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice” or “AseraCare”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Under the terms of the agreement, Amedisys acquired 100 percent of the ownership interests in AseraCare Hospice for a cash purchase price of $235 million, which is inclusive of a $32 million tax asset bringing the net purchase price to $203 million.

  • Thomson Reuters StreetEvents

    Edited Transcript of AMED earnings conference call or presentation 7-May-20 3:00pm GMT

    Q1 2020 Amedisys Inc Earnings Call

  • GlobeNewswire

    Amedisys to Present at the 2020 Jefferies Virtual Healthcare Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 2020 Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • CEO Spins The Golden Rule Into Business Gold
    Investor's Business Daily

    CEO Spins The Golden Rule Into Business Gold

    Amedisys CEO Paul Kusserow doesn't try to lead. He aims to serve instead. And in the process he's built a winning company with heart.

  • 12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies
    MarketWatch

    12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies

    DEEP DIVE The COVID-19 pandemic has accelerated some health-care trends while opening people’s eyes to others that now seem obvious. Analysts at investment bank Jefferies have listed stocks of companies they argue are likely winners and losers from those trends.

  • GlobeNewswire

    Amedisys to Present at RBC Capital Markets 2020 Global Healthcare Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at RBC Capital Markets 2020 Global Healthcare Conference on Tuesday, May 19, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • GlobeNewswire

    Amedisys to Present at the UBS Virtual Global Healthcare Conference 2020

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the UBS Global Healthcare Conference 2020 on Monday, May 18, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • GlobeNewswire

    Amedisys Reports First Quarter 2020 Financial Results

    BATON ROUGE, La., May 06, 2020 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020. Three-Month Periods Ended.

  • A Look At The Intrinsic Value Of Amedisys, Inc. (NASDAQ:AMED)
    Simply Wall St.

    A Look At The Intrinsic Value Of Amedisys, Inc. (NASDAQ:AMED)

    Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Amedisys, Inc...

  • GlobeNewswire

    Amedisys Celebrates More Than 8,000 Nurses During National Nurses Month

    Amedisys, Inc. (AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Month by honoring more than 8,000 nurses who call the company home. Traditionally, National Nurses Week begins each year on May 6 and ends on May 12, Florence Nightingale’s birthday. With the World Health Organization declaring 2020 as the Year of the Nurse and Midwife, this celebration has been extended to the entire month.

  • GlobeNewswire

    Amedisys to Present at the BofA Securities 2020 Virtual Health Care Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • GlobeNewswire

    Amedisys Signs Definitive Agreement to Acquire AseraCare Hospice

    Amedisys, Inc. (AMED), a leading provider of home health, hospice and personal care, announced today that it has, through one of its wholly owned subsidiaries, signed a definitive agreement to acquire Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Founded in 1994, AseraCare Hospice cares for more than 2,100 patients daily and employs more than 1,200 hospice professionals in 44 locations across 14 states, generating approximately $117 million in annual revenues. Under the terms of the agreement, expected to close on, or around, June 1, 2020, pending regulatory approvals, Amedisys will acquire 100 percent of the ownership interests in AseraCare Hospice for a cash purchase price of $235 million, which is inclusive of a $32 million tax asset bringing the net purchase price to $203 million.

  • Amedisys  Breaks Out To New Highs
    Investor's Business Daily Video

    Amedisys Breaks Out To New Highs

    Amedisys, a nursing home care provider, broke out over a 202.86 entry after clearing an early entry at 190.50 last week. This was an outside day for a long-term leader.